Mechanistically, SESN2 inhibited platelet-derived growth factor receptor β-mediated lung regeneration and injury repair by promoting autophagic degradation of Keap1 to activate the Nrf2–Keap1 pathway that protected against pulmonary emphysema (101, 116). The gene discussed is KEAP1; the disease is pulmonary emphysema.